This study demonstrated the feasibility of pharmacologically targeting NAA enzymatic pockets, providing a foundation for the future development of more specific and potent inhibitors to dissect NAA10′s function in cancer and assess its therapeutic relevance. Here, NAA10 is linked to cancer.